Suraksha Diagnostic Limited, a major provider of diagnostic services in Kolkata, is all set to launch its Initial Public Offering (IPO). The IPO subscription will open on November 29, 2024, and close on December 3, 2024. This is an exciting opportunity for investors to explore a growing company in the healthcare industry.
IPO Price Band and Lot Size
The price band for the Suraksha Diagnostic IPO has been fixed between ₹420 and ₹441 per share, with each share having a face value of ₹2. Investors can apply for the IPO in multiples of 34 shares per lot, making the minimum investment size ₹14,280
Total IPO Size and Distribution
The total IPO issue size is ₹846.25 crore. Here’s how the shares will be allocated:
- 50% reserved for Qualified Institutional Buyers (QIBs)
- 15% reserved for Non-Institutional Investors (NIIs)
- 35% reserved for Retail Investors
Important Dates to Remember
- Anchor Investor Bidding: November 28, 2024
- IPO Open Date: November 29, 2024
- IPO Close Date: December 3, 2024
- Allotment Finalization: December 4, 2024
- Refund Initiation: December 5, 2024
- Shares Credited to Demat Accounts: December 5, 2024
- IPO Listing Date: The IPO is scheduled to be listed on NSE and BSE on December 6, 2024.
Suraksha Diagnostic is a forward-thinking diagnostic chain that leverages advanced technology. It specializes in offering comprehensive pathology and radiology services, along with medical consultations, through its wide-reaching operational network.
The Suraksha Diagnostic IPO provides an opportunity to invest in a well-established player in the diagnostic services market. As healthcare demand grows in India, companies like Suraksha are poised to benefit. Conducting detailed research and seeking guidance from a financial advisor is recommended before making investment decisions.
